ProShare Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $634K | Sell |
|
|||||
|
2025
Q1 | $806K | Sell |
|
|||||
|
2024
Q4 | $1.49M | Buy |
|
|||||
|
2024
Q3 | $993K | Buy |
|
|||||
|
2024
Q2 | $614K | Sell |
|
|||||
|
2024
Q1 | $783K | Buy |
|
|||||
|
2023
Q4 | $536K | Buy |
|
|||||
|
2023
Q3 | $356K | Buy |
|
|||||
|
2023
Q2 | $188K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $205K | Buy |
|
|||||
|
2022
Q3 | $204K | Buy |
|
|||||
|
2022
Q2 | $188K | Sell |
|
|||||
|
2022
Q1 | $298K | Sell |
|
|||||
|
2021
Q4 | $476K | Buy |
|
|||||
|
2021
Q3 | $274K | Sell |
|
|||||
|
2021
Q2 | $306K | Buy |
|
|||||
|
2021
Q1 | $180K | Buy |
|
|||||
|
2020
Q4 | $156K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $207K | Buy |
|
|||||
|
2018
Q4 | $266K | Buy |
|